Product Overview
The ADVIA Centaur SARS-CoV-2 Total (COV2T) is an in vitro diagnostic assay intended for the qualitative and semi-quantitative detection of total antibodies to SARS-CoV-2 in human serum and plasma.
Principle of the Procedure
The assay uses a solid phase with a preformed complex of microparticles and biotinylated SARS-CoV-2 spike 1 RBD recombinant antigens to capture anti-SARS-CoV-2 antibodies in the sample.
The results of the assay should not be interpreted as an indication or degree of immunity or protection from infection.
Warnings and Precautions
The product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories.
Caution: Federal (USA) law restricts this device to sale by or on the order of a licensed healthcare professional.
Manual:
Download: ADVIA Centaur SARS-CoV-2 Total (COVZT) User Manual
Chat: Powered By VoiceSphere